![Carol Lynch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol Lynch
Corporate Officer/Principal at Sandoz, Inc.
Network origin in Carol Lynch first degree
Entity | Entity type | Industry | |
---|---|---|---|
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carol Lynch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Galderma Laboratories LP
![]() Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director of Finance/CFO | |
Temple University School of Medicine | College/University | Doctorate Degree | |
SCHOTT PHARMA AG & CO. KGAA | Medical Specialties | Chairman | |
STADA ARZNEIMITTEL | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharma (Sweeden) | Sales & Marketing | ||
Novartis Healthcare Philippines, Inc. | Corporate Officer/Principal | ||
Novartis Pharmaceuticals
![]() Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
University of Münster | College/University | Graduate Degree | |
GFK AG | Miscellaneous Commercial Services | Director/Board Member | |
Fougera Pharmaceuticals, Inc.
![]() Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
CASI PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Macrophage Therapeutics, Inc.
![]() Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Miscellaneous Commercial Services | Chief Operating Officer | |
MAYNE PHARMA GROUP LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Drexel University | College/University | Graduate Degree | |
Villanova University | College/University | Undergraduate Degree | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wyeth Pharmaceuticals LLC
![]() Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bristol-Myers Squibb Canada Co.
![]() Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
York University | College/University | Undergraduate Degree | |
Concordia University | College/University | Masters Business Admin | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca Canada, Inc.
![]() AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Investor Relations Contact | |
Galderma Holding SA
![]() Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nidda German Topco GmbH
![]() Nidda German Topco GmbH MiscellaneousMiscellaneous Part of Nidda Topco SARL, Nidda German Topco GmbH is an investment holding company. The company is based in Bad Vilbel, Germany. The CEOs of the company are Andreas Grundhöfer and Peter Goldschmidt. | Miscellaneous | Chief Executive Officer |
Statistics
International
United States | 14 |
Germany | 8 |
Canada | 6 |
United Kingdom | 3 |
Sweden | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 7 |
Commercial Services | 4 |
Miscellaneous | 2 |
Operational
Corporate Officer/Principal | 17 |
Director/Board Member | 4 |
Undergraduate Degree | 3 |
Chief Executive Officer | 3 |
Investor Relations Contact | 2 |
Most connected contacts
Insiders | |
---|---|
James E. Goldschmidt | 12 |
Peter Goldschmidt | 12 |
Sheila Frame | 8 |
Brant Schofield | 4 |
John Pakulski | 2 |
- Stock Market
- Insiders
- Carol Lynch
- Company connections